Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Operating Expenses | 2,544 | 2,785 | 3,407 | 2,126 | 672 |
| Operating Income | -2,544 | -2,785 | -3,407 | -2,126 | -672 |
| Interest Expense | 20 | 13 | 5 | 4 | 0 |
| Other Income | -180 | 622 | 822 | -1,485 | -198 |
| Pre-tax Income | -2,743 | -2,176 | -2,590 | -3,616 | -870 |
| Net Income Continuous | -2,743 | -2,176 | -2,590 | -3,616 | -870 |
| Net Income | $-2,743 | $-2,176 | $-2,590 | $-3,616 | $-870 |
| EPS Basic Total Ops | -13.75 | -11.00 | -16.01 | -18.75 | -7.50 |
| EPS Basic Continuous Ops | -13.73 | -11.09 | -16.53 | -18.66 | -8.75 |
| EPS Diluted Total Ops | -13.75 | -11.00 | -16.01 | -18.75 | -7.50 |
| EPS Diluted Continuous Ops | -13.73 | -11.09 | -16.53 | -18.66 | -8.75 |
| EBITDA(a) | $-2,543 | $-2,784 | $-3,406 | $-2,126 | $-672 |